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World Cancer Day (WCD) is celebrated on February 4th each year around the world 
to remind the efforts done by united nations, World Health Organization (WHO), and 
other governmental and non-governmental health organizations with the aim of de-
livering the real message about cancer and its treatments to fight against this fatal 
disease through uniting all the people on global basis (1-4). In brief, cancer is a large 
group of different disorders involving unregulated cell growth. In malignancy, cells 
divide and grow uncontrollably to form malignant tumors and to invade neighboring 
parts of the body. The cancer tumor may spread to more distant parts of the body 
through blood or lymphatic systems (5-8). It has been observed that most of the can-
cer cases and related deaths happen in less developed countries that this situation is 
expected to get worse by 2030. Therefore, it is very crucial to get control over such 
condition throughout the world. Furthermore, WCD aims to save millions of prevent-
able deaths every year by raising alertness and by educating people about malig-
nancy, while forcing the governments throughout the world to take action against this 
disease (2-8). The day is also a key chance for cancer patients to ensure that world 
leaders stick to the promises they made at the United Nations Summit for reducing 
the cancer and its impacts. During this particular occasion, participants try to promote 
healthy lifestyles, balanced diet, regular physical activity, weight management, as 
well as using antioxidants in order to diminish the risk of malignancies (1-8). Further-
more, this day is celebrated to plan certain new strategies and to imply various new 
programs in order to make people aware of this disorder. WCD is also celebrated to 
make non-patient people aware about the preventive methods and the risk factors 
of cancer (2-8). The theme of WCD of 2014 is "Debunk the Myths" because some 
people believe that if they contact or live with a patient who has cancer, they would 
get cancer as well. The day is, therefore, distinguished to eradicate such types of the 
social myths (5-13) and to make certain concepts about different aspects of the ma-
lignancy, such as its symptoms, causing factors and treatment (1, 3, 9).  Furthermore, 
on this day, some of activities are organized to indicate that cancer patients should 
not be treated distinctly, while they are entitled to the same rights as normal people 
in the society (14-19). Although they have less chances of existence, they should be 
fulfilled their wishes by their relatives.  It should not make them sense that the treat-
ment remedies are given them for existence as they are dying. In this regards, it is 
very important to make them feel better like a normal person. They should be also 
prepared a normal environment in their home and society.  It is essential that normal 
people avoid being overly sympathetic to them (20-27).
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